SLShan-Chi Liu

Shan-Chi Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shan-Chi Liu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Polyketides from a marine medicinal brown alga-derived fungal strain Hypomontagnella monticulosa SC1047

    by Hsiao-Yang Hsi, George Hsiao, Shih-Wei Wang, Wan-Ling Chang, Shu-Jung Huang, Shan-Chi Liu, Guang-Wei Chen, Tzong-Huei Lee


  • Open Access

    Isolated from Antrodia cinnamomea, 25S-antcin K suppresses the production of inflammatory cytokines and cartilage degradation in rheumatoid arthritis

    by Shan-Chi Liu, Tung-Ying Wu, Trung-Loc Ho, Chun-Hao Tsai, Wen-Hui Chung, Yen-You Lin, Yang-Chang Wu, Chih-Hsin Tang

  • High‐doseTiger‐Gianformula protects the knee joint from surgically induced osteoarthritis in rats

    by Pu‐Wei Hou, Shan‐Chi Liu, Gregory J. Tsay, Yuan‐Shiun Chang, Hui‐Chi Huang, Chih‐Hsin Tang, Hen‐Hong Chang

    Aim: Although the Tiger‐Gian formula (TGF) has proven clinically effective at improving the symptoms of knee osteoarthritis (KOA), the pharmacological effects and underlying mechanisms of TGF have not been examined in any animal model. This study assessed the effects of TGF in male Sprague‐Dawley rats with anterior cruciate ligament transection (ACLT) ‐induced KOA.Methods: Thirty rats underwent ACLT surgery and were assigned to either the control group, ACLT alone, ACLT + low‐dose TGF (1000 mg/kg), ACLT + high‐dose TGF (3000 mg/kg), or ACLT + celecoxib (30 mg/kg). All rats were subjected to micro‐computed tomography (micro‐CT), weight‐bearing behavioral testing, and histological inspections of the knee joint for evidence of structural changes in articular bone, cartilage and synovium.Results: After 6 weeks, force discrepancies in weight‐bearing distribution between the normal hind and postoperative limbs revealed superiority with high‐dose TGF (18.00 ± 5.93 g) and celecoxib (18.68 ± 5.29 g) versus both ACLT alone (41.29 ± 7.06 g) and low‐dose TGF (37.00 ± 7.40 g). Micro‐CT images revealed that high‐dose TGF and celecoxib similarly improved subchondral bone architecture, protected articular cartilage after ACLT, and downregulated proinflammatory cytokines interleukin‐1β and tumor necrosis factor‐α in the cartilage and synovial sections.Conclusion: High‐dose TGF induced the smallest amount of KOA‐associated bone loss. Anti‐inflammatory, anti‐oxidative, and immunomodulatory effects of TGF were accompanied by reductions in proinflammatory cytokines and improvements in pain and function. TGF‐induced anti‐osteoporotic activity and inhibition of cartilage degradation were reflected by micro‐CT and histological analysis. The findings help to explain how TGF alleviates symptoms of KOA.


  • Open Access

    Nesfatin-1 stimulates CCL2-dependent monocyte migration and M1 macrophage polarization: implications for rheumatoid arthritis therapy

    by Jun-Way Chang, Shan-Chi Liu, Yen-You Lin, Xiu-Yuan He, Yi-Syuan Wu, Chen-Ming Su, Chun-Hao Tsai, Hsien-Te Chen, Yi-Chin Fong, Sung-Lin Hu, et al.

    Rheumatoid arthritis (RA) is a prototypic inflammatory disease, characterized by the infiltration of proinflammatory cytokines into the joint synovium and the migration of mononuclear cells into inflammatory sites. The adipokine nesfatin-1 is linked to inflammatory events in various diseases, although its role in RA pathology is uncertain. Analysis of the Gene Expression Omnibus GSE55235 dataset revealed high levels of expression of the adipokine nesfatin-1 in human RA synovial tissue. Similarly, our human synovial tissue samples exhibited increasing levels of nesfatin-1 expression and Ccl2 mRNA expression. Nesfatin-1-induced stimulation of CCL2 expression and monocyte migration involved the MEK/ERK, p38 and NF-κB signaling pathways. Notably, nesfatin-1-induced increases in CCL2 expression favored M1 macrophage polarization, which increased the expression of proinflammatory cytokines IL-1β, IL-6 and TNF-α. Finally, nesfatin-1 shRNA ameliorated the severity of inflammatory disease and reduced levels of M1 macrophage expression in CIA mice. Our studies confirms that nesfatin-1 appears to be worth targeting in RA treatment.

  • Open Access

    Melatonin abolished proinflammatory factor expression and antagonized osteoarthritis progression in vivo

    by Shan-Chi Liu, Chun-Hao Tsai, Yu-Han Wang, Chen-Ming Su, Hsi-Chin Wu, Yi-Chin Fong, Shun-Fa Yang, Chih-Hsin Tang

    Progressive structural changes in osteoarthritis (OA) involve synovial inflammation and angiogenesis, as well as activation of the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin (IL)-8, and the angiogenic factor vascular endothelial growth factor (VEGF). The endogenous hormone melatonin (N-acetyl-5-methoxytryptamine) is involved in antioxidative and anti-inflammatory activities, but how it antagonizes OA progression via its specific receptors is unclear. Here, we demonstrate that the MT1melatonin receptor, but not the MT2receptor, is highly expressed in normal tissue and only minimally in OA tissue. By targeting the MT1receptor, melatonin reversed OA-induced pathology and effectively reduced levels of TNF-α, IL-8, and VEGF expression in OA synovial fibroblasts and synovium from rats with severe OA. Interestingly, we found that the anabolic activities of melatonin involved the MT1receptor, which upregulated microRNA-185a through the PI3K/Akt and ERK signaling pathways in OA synovial fibroblasts. Our investigation confirms the role of the MT1receptor in melatonin-induced anti-catabolic effects in OA disease.